Cerus Corp. Stock
Price
Target price
€2.03
€2.03
-1.770%
-0.036
-1.770%
€3.26
19.07.24 / Tradegate
WKN: 905249 / Symbol: CERS / Name: Cerus Corp / Stock / Healthcare Equipment & Supplies / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Cerus Corp. Stock
A loss of -1.770% shows a downward development for Cerus Corp..
Our community is currently high on Cerus Corp. with 4 Buy predictions and 0 Sell predictions.
As a result the target price of 3 € shows a positive potential of 48.08% compared to the current price of 2.03 € for Cerus Corp..
Pros and Cons of Cerus Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cerus Corp. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Cerus Corp. | -1.770% | 12.182% | 27.985% | -21.867% | -4.434% | -51.531% | -58.917% |
scPharmaceuticals | -4.170% | -1.896% | 10.106% | -44.800% | -28.000% | -19.612% | - |
Orasure Tech | -4.460% | -1.531% | -8.095% | -1.531% | -48.188% | -55.581% | -48.313% |
SI-BONE Inc | -3.250% | 11.194% | 31.858% | -32.883% | -21.579% | -41.339% | - |
Comments
Cerus Co. (NASDAQ: CERS) had its price target raised by analysts at Cantor Fitzgerald from $3.00 to $4.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for CERS provided by MarketBeat
Cerus Co. (NASDAQ: CERS) is now covered by analysts at Craig Hallum. They set a "buy" rating and a $5.00 price target on the stock.
Show more
Ratings data for CERS provided by MarketBeat
Cerus Co. (NASDAQ: CERS) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $3.00 price target on the stock.
Show more
Ratings data for CERS provided by MarketBeat